Loxo Oncology - Ownership and Business Overview

Life ScienceCompany

Loxo Oncology Ownership

Who owns Loxo Oncology?

Loxo Oncology is owned by Eli Lilly. It was acquired on January 7, 2019.

Was Loxo Oncology formerly PE-backed?

Yes. Loxo Oncology was formerly owned by 1 private investor.

Loxo Oncology Business Overview

Where is Loxo Oncology headquartered?

Loxo Oncology is headquartered in Stamford, Connecticut.

What sector is Loxo Oncology in?

Loxo Oncology is a life science company.

When was Loxo Oncology founded?

Loxo Oncology was founded in 2013.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Loxo Oncology, Inc.

281 Tresser Boulevard, 9th Floor,
Stamford, Connecticut 06901
United States,
(203) 653-3880
www.loxooncology.com

Loxo Oncology, Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. Loxo Oncology, Inc. was founded in 2013 and is based in Stamford, Connecticut.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.